Gain Therapeutics GANX
NASDAQ GANX
$1.29 +0.10 (+8.40%)
At close: Oct 22, 2026 · 4:00 PM EDT

Gain Therapeutics (GANX) Return on Assets [ROA] (2021 - 2026)

Updated

Gain Therapeutics (GANX) recorded Return on Assets [ROA] of -117.72% in Q2 2026, up 55.58 percentage points from -173.30% a year earlier but down 15.50 percentage points from the prior quarter.

Analysis

Gain Therapeutics (GANX) Return on Assets [ROA] (2021 - 2026) Analysis & Trends

For FY2025, Gain Therapeutics reported Return on Assets [ROA] of -115.39%, up 17.43 percentage points from FY2024.

  • Annual Return on Assets [ROA] has a four-year change of -58.22 percentage points (FY2021 to FY2025).
  • Across earlier years, Return on Assets [ROA] came in at -132.83% in FY2024 (-28.55 pp), -104.28% in FY2023 (-48.51 pp), -55.77% in FY2022 (+1.41 pp) and -57.18% in FY2021.
  • Quarterly Return on Assets [ROA] has ranged from -186.41% in Q3 2025 to -28.04% in Q3 2021 over the past five years.
  • On a year-over-year basis, Return on Assets [ROA] has increased for three consecutive quarters, with an average year-over-year change of +0.39 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 74.03 percentage points in Q1 2026, against a drop of 83.73 percentage points in Q3 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at -102.22% (Q1 2026), -119.33% (Q4 2025) and -186.41% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 8.08%
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 4.65%
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 2.45%
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 10.60%
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 9.10%
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 9.29%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -6.13%
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 2.14%
10 Gain Therapeutics 54.89 Mn -4.40 Mn - -117.72%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -117.72%
Mar 31, 2026 -102.22%
Dec 31, 2025 -119.33%
Sep 30, 2025 -186.41%
Jun 30, 2025 -173.30%
Mar 31, 2025 -176.25%
Dec 31, 2024 -154.11%
Sep 30, 2024 -127.33%
Jun 30, 2024 -127.91%
Mar 31, 2024 -127.43%
Dec 31, 2023 -136.16%
Sep 30, 2023 -137.32%
Jun 30, 2023 -111.45%
Mar 31, 2023 -85.67%
Dec 31, 2022 -67.11%
Sep 30, 2022 -53.59%
Jun 30, 2022 -46.75%
Mar 31, 2022 -38.42%
Dec 31, 2021 -34.07%
Sep 30, 2021 -28.04%
API Access

Gain Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=GANX&period=max&api_key=YOUR_API_KEY